期刊文献+

VEGF靶向荷钆PLA—PEG—PLL纳米探针的制备及其在小肝癌成像中的价值 被引量:3

Synthesis of the PLA-PEG-PLL gadolinium loaded nanoprobe targeted to vascular endothelial growth fac- tor used for the molecular imaging of micro-hepatic carcinoma
原文传递
导出
摘要 目的制备VEGF靶向荷钆纳米探针,并研究其在小肝癌特异性成像中的价值。方法采用生物相容性高分子材料聚乳酸-聚乙二醇一聚赖氨酸(PLA—PEG-PLL)纳米粒为载体,分别将血管内皮生长因子(VEGF)抗体及钆基接合至载体表面得到靶向纳米探针。体外MR成像测定其驰豫率,再利用种植型H22肝癌小鼠模型进行靶向纳米探针MR增强扫描,探讨皮下种植肝癌及微小病灶的强化表现特点。结果制备的靶向探针粒径和Zata电位分别为(85.8±7.2)nm和(21.63±2.4)mV,当其浓度为8.0μmol/ml时测得的R1值为18.394mmol·ml-1·S-1。靶向探针MR增强扫描显示皮下较大肝癌及小肝癌均表现为明显的特异性靶向延迟期增强,强化峰值分别在2h及3h时出现,而非靶向纳米粒增强扫描时肿瘤强化不明显。结论成功制备了合适的高驰豫率VEGF靶向PLA—PEG-PLL荷钆纳米探针,并实现了小肝癌的特异性靶向成像。该纳米探针在肝癌检测方面具有较好的临床应用前景。 Objective This study aims to synthesize a novel gadolinium loaded nanoprobe targe- ted to vascular endothelial growth factor (VEGF) and assess its clinical value for imaging micro hepat- ic carcinoma. Methods A carrier was made by the biocompatible polymer material polylactic acid-po- lyethylene glycol-poly-L-lysinenanoparticles (PLA-PEG-PLLs). The targeted nanoprobe was obtained with anti-VEGF antibody and gadolinium (Gd) bonding to the surface of the carrier. MRI in vitro de- termined the T1 relaxivity of the nanoprobe. A live cancer model enhanced MR scan was performed by injecting targeted nanoprobes into the tail vein of grafted H22 tumor mice. The enhanced characteris- tics of the subcutaneous tumors and micro-hepatic carcinoma were then reviewed. Results The parti- cle size of the VEGF-targeted PLA-PEG-PLL gadolinium loaded nanoprobe was 85.8± 7.2 nm with a zeta potential of 21.63±2.4 inV. The R1 relaxivity of the targeted nanoprobe was 18. 394 mmol/s at 3.0 T when its gadolinium concentration was 8.0 μmol/ml. The enhanced MR scan using targeted probes showed that the big and micro-subcutaneous cancer exhibited a specifically delayed enhancement with an enhanced peak value at 2 or 3 hours, rather than the enhancement of the tumor using the non- targeted nanoparticles. Conclusion In conclusion, the VEGF targeted PLA-PEG-PLL gadolinium loaded nanoprobe was synthesized successfully, showed a high relaxivity, achieved targeted imaging of the micro-hepatic carcinoma, and exhibits a promising potential in the detection of this liver cancer.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第3期215-219,共5页 Chinese Journal of Hepatobiliary Surgery
基金 山东省科技攻关项目(2008GG30002028) 国家自然科学基金(81241057) 山东省自然科学基金(ZR2012HM012)
关键词 纳米探针 VEGF 早期肝癌 靶向成像 Nanoprobe Vascular endothelial growth factor Micro-hepatic carcinoma Targeted imaging Gadolinum
  • 相关文献

参考文献17

  • 1Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nod- ules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma [J]. Hepatology, 2008,47:97-104.
  • 2Wessels JT, Busse AC, Mahrt J, et al. In vivo imaging in ex perimental preelinical tumor research-a review[J]. Cytometry A, 2007,71:542-549.
  • 3Roncalli M, Borzio M, Di Tommaso L. Hepatocellular dys- plastic nodules[J]. Hepatol Res, 2007,37:125-134.
  • 4Liu Y, Chen Z, Liu C, et al. Gadolinium-loaded polymeric nanoparticles modified with anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer[J]. Biomateri- als, 2011,32:5167-5176.
  • 5Zeeh CJ, Reiser MF, Herrmann KA. Imaging of hepatocellu- lar carcinoma by computed tomography and magnetic reso- nance imaging: state of the art [J]. Dig Dis, 2009, 27: 114-124.
  • 6Hussain SM, Reinhold C, Mitchell DG. Cirrhosis and lesion characterization at MR imaging[J]. Radio Graphics, 2009,29: 1637-1652.
  • 7van den Bos IC, Hussain SM, Terkivatan T, et al. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liv- er- demonstration on serial MR imaging[J]. J Magn Reson Imaging, 2006,24 :1071-1080.
  • 8Folkman J. What is the evidence that tumors are angiogenesis dependent[J]. J Nat 1 Cancer Inst, 1990,82 : 4-6.
  • 9Weidner N, Folkman J, Pozza F, et al. Tumor angiogernosis.. a new significant and independent prognostic indicator in early stage breast carcinoma[J]. J Natl Cancer Inst, 1992, 84: 1875-1887.
  • 10Willatt JM, Hussain HK, Adusumilii S, et al. MR imaging of hepatocellular carcinoma in the cirrhotic liver., challenges and eontroversies[J]. Radiology, 2008,247 : 311-30.

二级参考文献17

  • 1Rode A. Radiological diagnosis of hepatocellular carcinoma in 2010 Cancer[J]. Radiother, 2011,15:7-12.
  • 2Sanvicens N, Marco MP. Multifunctional nanoparticales-prop- erties and prospects for their use in human medicine[J]. Trends in Biotechnology, 2008,26: 425-433.
  • 3Saar B, Kellner-Weldon F. Radiological diagnosis of hepato- cellular carcinoma[J]. Liver Int, 2008,28 : 189-199.
  • 4Cabrera R, Nelson DR. Review artiele: the management of hepatocellular carcinoma[J]. Aliment Pharmacol Ther, 2010, 31:461-476.
  • 5Lai Y, Yin W, Liu J, et al. One-pot green synthesis and bio application of 1 arginine capped superparamagnetic Fe304 ano- particles[J]. Nanoscale Res Lett, 2009,5:302-307.
  • 6Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise[J]. Pharmacology & Therapeutics, 2010,128:324-335.
  • 7Oghabian MA, Farahbakhsh NM, et al. Potential use of nano- particle based contrast agents in MRI: a molecular imaging perspective[J].J Biomed Nanotechnol, 2010,6:203-213.
  • 8Ferrucei JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen, review of the first 5 years[J]. AJR Am J Roentgenol, 1990,155 : 943-950.
  • 9Tanimoto A. Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma[J]. Eur J Radiol, 2006,58:200-216.
  • 10Yi T,Yamashita Y, Arakawa A, et al. Detection of hepatocel- lular carcinoma arisingin cirrhotic livers: comparison of gado linium and ferumoxide- enhanced MRI maging[J]. AJR, 1999,172:1547 -1554.

共引文献9

同被引文献25

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部